• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Discovery Laboratories Inc

+ Add to Watchlist


1.2600 USD 0.0100 0.80%

As of 20:10:00 ET on 12/19/2014.

Company Profile for Discovery Laboratories Inc (DSCO)

Discovery Laboratories, Inc. is a biopharmaceutical company that develops its proprietary surfactant technology as Surfactant Replacement Therapies (SRT) for respiratory diseases. Through this technology, pulmonary surfactants have the potential to be developed into a series of respiratory therapies for patients in the neonatal care unit, critical care unit and other hospital settings.

Contact Information

Discovery Laboratories Inc

2600 Kelly Road
Suite 100
Warrington, PA 18976-3622
United States
Phone: 1-215-488-9300
Fax: 1-215-488-9301

Key Executives for Discovery Laboratories Inc (DSCO)

John G CooperPresident/CEOJohn A TattorySenior VP/CFO
Steven G SimonsonSenior VP/Chief Dev OfcrThomas F MillerSenior VP/COO
Mary B TempletonSenior VP/Secy/Gen CnslKathryn A ColeSenior VP:Human Resources
Russell G Clayton "Rusty"Senior VP:Research & DevLawrence WeinsteinVP:Medical Device Development
Thomas C HoyVP:Manufacturing OpsWilliam C RobertsVP:Investor Relations
Michael L MageeVP:Quality Operations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil